These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 16914559)

  • 1. Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family).
    Yonezawa A; Masuda S; Yokoo S; Katsura T; Inui K
    J Pharmacol Exp Ther; 2006 Nov; 319(2):879-86. PubMed ID: 16914559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3).
    Bourdet DL; Pritchard JB; Thakker DR
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1288-97. PubMed ID: 16141367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of organic cation transporter 3 (SLC22A3) expression for the cytotoxic effect of oxaliplatin in colorectal cancer.
    Yokoo S; Masuda S; Yonezawa A; Terada T; Katsura T; Inui K
    Drug Metab Dispos; 2008 Nov; 36(11):2299-306. PubMed ID: 18710896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organic cation transporter OCT/SLC22A and H(+)/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agents.
    Yonezawa A; Inui K
    Biochem Pharmacol; 2011 Mar; 81(5):563-8. PubMed ID: 21144842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
    Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
    J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of guanidine compounds by human organic cation transporters, hOCT1 and hOCT2.
    Kimura N; Masuda S; Katsura T; Inui K
    Biochem Pharmacol; 2009 Apr; 77(8):1429-36. PubMed ID: 19426682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of
    López Quiñones AJ; Wagner DJ; Wang J
    Mol Pharmacol; 2020 Aug; 98(2):109-119. PubMed ID: 32487736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin.
    Holzer AK; Manorek GH; Howell SB
    Mol Pharmacol; 2006 Oct; 70(4):1390-4. PubMed ID: 16847145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.
    Kitada N; Takara K; Minegaki T; Itoh C; Tsujimoto M; Sakaeda T; Yokoyama T
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):577-84. PubMed ID: 18030470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atenolol Renal Secretion Is Mediated by Human Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Proteins.
    Yin J; Duan H; Shirasaka Y; Prasad B; Wang J
    Drug Metab Dispos; 2015 Dec; 43(12):1872-81. PubMed ID: 26374172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxic pyridinium metabolites of haloperidol are substrates of human organic cation transporters.
    Kang HJ; Lee SS; Lee CH; Shim JC; Shin HJ; Liu KH; Yoo MA; Shin JG
    Drug Metab Dispos; 2006 Jul; 34(7):1145-51. PubMed ID: 16624869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters.
    Ming X; Ju W; Wu H; Tidwell RR; Hall JE; Thakker DR
    Drug Metab Dispos; 2009 Feb; 37(2):424-30. PubMed ID: 18971316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa).
    Zhang L; Schaner ME; Giacomini KM
    J Pharmacol Exp Ther; 1998 Jul; 286(1):354-61. PubMed ID: 9655880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug specificity and intestinal membrane localization of human organic cation transporters (OCT).
    Müller J; Lips KS; Metzner L; Neubert RH; Koepsell H; Brandsch M
    Biochem Pharmacol; 2005 Dec; 70(12):1851-60. PubMed ID: 16263091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug transporters of platinum-based anticancer agents and their clinical significance.
    Burger H; Loos WJ; Eechoute K; Verweij J; Mathijssen RH; Wiemer EA
    Drug Resist Updat; 2011 Feb; 14(1):22-34. PubMed ID: 21251871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the kinetic characteristics of inhibitory effects exerted by biguanides and H2-blockers on human and rat organic cation transporter-mediated transport: Insight into the development of drug candidates.
    Umehara KI; Iwatsubo T; Noguchi K; Kamimura H
    Xenobiotica; 2007 Jun; 37(6):618-34. PubMed ID: 17614008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-resistance of platinum derivatives in H-1R, a cisplatin-resistant cell line.
    Negoro K; Yamano Y; Nakashima D; Saito K; Nakatani K; Shiiba M; Bukawa H; Yokoe H; Uzawa K; Wada T; Tanzawa H; Fujita S
    Oncol Rep; 2009 Feb; 21(2):443-9. PubMed ID: 19148521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3.
    Hayer-Zillgen M; Brüss M; Bönisch H
    Br J Pharmacol; 2002 Jul; 136(6):829-36. PubMed ID: 12110607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2.
    Jouan E; Le Vee M; Denizot C; Da Violante G; Fardel O
    Fundam Clin Pharmacol; 2014 Feb; 28(1):65-77. PubMed ID: 22913740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport of paraquat by human organic cation transporters and multidrug and toxic compound extrusion family.
    Chen Y; Zhang S; Sorani M; Giacomini KM
    J Pharmacol Exp Ther; 2007 Aug; 322(2):695-700. PubMed ID: 17495125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.